Author

M. S. Pedersen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:E. coli· 2 Approach:experimental assay· 2 Assay:whole-genome sequencing· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1 Research Focus:variant calling· 1

Frequent Co-Authors

S. Mollerup· 2 shared C. Elmeskov· 1 shared C. Fernandez-Antunez· 1 shared D. Frees· 1 shared H. Gumpert· 1 shared H. Westh· 1 shared J. Bukh· 1 shared J. Dubuisson· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

S. Mollerup

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Piperacillin-Tazobactam Resistance Mechanisms in Escherichia coli and Identification of a CTX-M-255 β-Lactamase Selectively Conferring Resistance to Penicillin/β-Lactamase Inhibitor Combinations

M. R. Andreasen, K. Hartung Hansen, M. S. Pedersen, S. Mollerup, L. Jelsbak, K. Schonning

The paper identifies four resistance mechanisms in E. coli resistant to piperacillin-tazobactam but susceptible to third-generation cephalosporins, including a novel CTX-M-255 β-lactamase resistant to inhibitors.

bioRxiv · Sep 21, 2022 · PreprintMicrobiology

Rapid in vivo development of resistance to daptomycin in vancomycin-resistant Enterococcus faecium due to genomic rearrangements

S. Mollerup, C. Elmeskov, H. Gumpert, M. Pinholt, T. S. Sejersen, M. S. Pedersen, P. Worning, D. Frees, H. Westh

This study identifies genomic rearrangements as the mechanism for daptomycin resistance in VREfm after combination therapy.

bioRxiv · Sep 24, 2021 · PreprintMicrobiology

Efficient culture of SARS-CoV-2 in human hepatoma cells enhances viability of the virus in human lung cancer cell lines permitting the screening of antiviral compounds

S. Ramirez, C. Fernandez-Antunez, L. V. Pham, L. A. Ryberg, S. Feng, M. S. Pedersen, L. S. Mikkelsen, S. Belouzard, J. Dubuisson, J. M. Gottwein, U. Fahnoe, J. Bukh

This paper adapts SARS-CoV-2 to replicate more efficiently in human cells, enabling antiviral compound screening across multiple cell lines.

bioRxiv · Oct 4, 2020 · PreprintMicrobiology